| __timestamp | ACADIA Pharmaceuticals Inc. | Bio-Techne Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 30945000 |
| Thursday, January 1, 2015 | 73869000 | 40853000 |
| Friday, January 1, 2016 | 99284000 | 45187000 |
| Sunday, January 1, 2017 | 149189000 | 53514000 |
| Monday, January 1, 2018 | 187163000 | 55329000 |
| Tuesday, January 1, 2019 | 240385000 | 62413000 |
| Wednesday, January 1, 2020 | 319130000 | 65192000 |
| Friday, January 1, 2021 | 239415000 | 70603000 |
| Saturday, January 1, 2022 | 361575000 | 87140000 |
| Sunday, January 1, 2023 | 351619000 | 92493000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing insights
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals has consistently outpaced Bio-Techne Corporation in R&D investment. From 2014 to 2023, ACADIA's R&D expenses surged by nearly 480%, peaking in 2022. In contrast, Bio-Techne's R&D spending grew by approximately 210% during the same period. This strategic focus highlights ACADIA's aggressive pursuit of new therapies, while Bio-Techne maintains a steady, albeit slower, growth trajectory. Notably, 2023 saw a slight dip in ACADIA's R&D spending, suggesting a potential strategic pivot or market adjustment. As we look to the future, these trends underscore the dynamic nature of biotech innovation and the varying strategies companies employ to stay ahead in this rapidly evolving field.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds